BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26037906)

  • 21. Magnesium sulfate in eclampsia and pre-eclampsia: pharmacokinetic principles.
    Lu JF; Nightingale CH
    Clin Pharmacokinet; 2000 Apr; 38(4):305-14. PubMed ID: 10803454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [MgSO4-therapy in pre-eclampsia/eclampsia. Review of the literature].
    Minkov R; Aleksandrov K
    Akush Ginekol (Sofiia); 2003; 42 Suppl 2():24-7. PubMed ID: 14619751
    [No Abstract]   [Full Text] [Related]  

  • 23. Magnesium Sulphate for Eclampsia and Fetal Neuroprotection: A Comparative Analysis of Protocols Across Canadian Tertiary Perinatal Centres.
    De Silva DA; Sawchuck D; von Dadelszen P; Basso M; Synnes AR; Liston RM; Magee LA
    J Obstet Gynaecol Can; 2015 Nov; 37(11):975-87. PubMed ID: 26629718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnesium sulphate therapy in women with pre-eclampsia and eclampsia in Kuwait.
    Omu AE; Al-Harmi J; Vedi HL; Mlechkova L; Sayed AF; Al-Ragum NS
    Med Princ Pract; 2008; 17(3):227-32. PubMed ID: 18408392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obstetrician's risk perception on the prescription of magnesium sulfate in severe preeclampsia and eclampsia: A qualitative study in Brazil.
    Lotufo FA; Parpinelli MA; Osis MJ; Surita FG; Costa ML; Cecatti JG
    PLoS One; 2017; 12(3):e0172602. PubMed ID: 28301493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnesium sulphate for treatment of eclampsia: the Nigerian experience.
    Adewole IF; Oladokun A; Okewole AI; Omigbodun AO; Afolabi A; Ekele B; Audu LR; Obed Y
    Afr J Med Med Sci; 2000; 29(3-4):239-41. PubMed ID: 11713998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maternal and perinatal outcome of severe pre-eclampsia in Enugu, Nigeria after introduction of Magnesium sulfate.
    Ugwu EO; Dim CC; Okonkwo CD; Nwankwo TO
    Niger J Clin Pract; 2011; 14(4):418-21. PubMed ID: 22248941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of magnesium sulphate for the treatment of severe pre-eclampsia and eclampsia.
    Tukur J
    Ann Afr Med; 2009; 8(2):76-80. PubMed ID: 19805935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnesium sulphate in the treatment of eclampsia and pre-eclampsia: an overview of the evidence from randomised trials.
    Duley L; Neilson J
    Br J Obstet Gynaecol; 1997 Jun; 104(6):756-8. PubMed ID: 9197892
    [No Abstract]   [Full Text] [Related]  

  • 30. [Magnesium sulfate in obstetrics: current data].
    Azria E; Tsatsaris V; Goffinet F; Kayem G; Mignon A; Cabrol D
    J Gynecol Obstet Biol Reprod (Paris); 2004 Oct; 33(6 Pt 1):510-7. PubMed ID: 15567967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of magnesium sulfate in pre-eclampsia and eclampsia in teaching hospitals in Addis Ababa: a practice audit.
    Getaneh W; Kumbi S
    Ethiop Med J; 2010 Apr; 48(2):157-64. PubMed ID: 20608019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnesium sulfate exposure and neonatal intensive care unit admission at term.
    Girsen AI; Greenberg MB; El-Sayed YY; Lee H; Carvalho B; Lyell DJ
    J Perinatol; 2015 Mar; 35(3):181-5. PubMed ID: 25321647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of magnesium sulfate before 32 weeks of gestation: a European population-based cohort study.
    Wolf HT; Huusom L; Weber T; Piedvache A; Schmidt S; Norman M; Zeitlin J;
    BMJ Open; 2017 Jan; 7(1):e013952. PubMed ID: 28132012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reducing maternal mortality from preeclampsia and eclampsia in low-resource countries--what should work?
    Goldenberg RL; Jones B; Griffin JB; Rouse DJ; Kamath-Rayne BD; Trivedi N; McClure EM
    Acta Obstet Gynecol Scand; 2015 Feb; 94(2):148-55. PubMed ID: 25353716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnesium sulphate: a life saving drug.
    Thapa K; Jha R
    JNMA J Nepal Med Assoc; 2008; 47(171):104-8. PubMed ID: 19079372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feasibility of task-sharing with community health workers for the identification, emergency management and referral of women with pre-eclampsia, in Mozambique.
    Sevene E; Boene H; Vidler M; Valá A; Macuacua S; Augusto O; Fernandes Q; Bique C; Macete E; Sidat M; von Dadelszen P; Munguambe K;
    Reprod Health; 2021 Jul; 18(1):145. PubMed ID: 34229709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Magnesium sulphate in the treatment of eclampsia and pre-eclampsia: an overview of the evidence from randomised trials.
    Chien PF; Khan KS; Arnott N
    Br J Obstet Gynaecol; 1996 Nov; 103(11):1085-91. PubMed ID: 8916993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health Care Readiness in Management of Preeclampsia/Eclampsia in Ethiopia: Evidence from National Facility-Based Survey.
    Meazaw MW; Chojenta C; Forder P; Taddele T; Loxton D
    Risk Manag Healthc Policy; 2022; 15():1225-1241. PubMed ID: 35734013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pros and cons of magnesium sulfate as a tocolytic].
    Bozhinova S; Markova S; Tsvetkov Ts; Penkov V; Ivanova I
    Akush Ginekol (Sofiia); 2002; 41(6):17-22. PubMed ID: 12577499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A primary health care model for managing pre-eclampsia and eclampsia in low- and middle- income countries.
    Warren CE; Hossain SMI; Ishaku S; Armbruster D; Hillman E
    Reprod Health; 2020 Apr; 17(1):46. PubMed ID: 32252775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.